Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | INSM | RPRX | ||
| Company | Biogen Inc | Insmed Inc | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 191.06 | 147.98 | 47.00 | ||
| High | 191.06 | 149.20 | 47.33 | ||
| Low | 184.34 | 142.59 | 46.36 | ||
| Latest | 183.52 | 145.91 | 46.42 | ||
| Change | -7.54 | -1.69 | -0.52 | ||
| % Change | -3.95% | -1.14% | -1.11% | ||
| Volume | 341,146 | 1,621,365 | 1,329,060 | ||
| 20-Day Average Volume | 888,265 | 2,243,336 | 3,460,199 | ||
| Previous Close | 191.06 | 147.60 | 46.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 185.85 | 143.41 | 46.20 | ||
| 20-Day Raw Stochastic | 35.47% | 68.43% | 55.27% | ||
| 20-Day Relative Strength | 49.47 | 47.26 | 59.32 | ||
| Weighted Alpha | +38.19 | +49.81 | +50.32 | ||
| Today's Opinion | 72% Buy | 56% Sell | 100% Buy | ||
| Previous Opinion | 96% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.85% since 03/20/26 | +7.12% since 03/20/26 | +2.43% since 03/20/26 | ||
| Low | 180.33 on 03/24/26 | 137.20 on 03/24/26 | 45.04 on 03/23/26 | ||
| High | 192.27 on 03/26/26 | 149.88 on 03/26/26 | 47.54 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -3.65% since 02/27/26 | -2.44% since 02/27/26 | +0.54% since 02/27/26 | ||
| Low | 180.33 on 03/24/26 | 135.73 on 03/20/26 | 44.73 on 03/20/26 | ||
| High | 192.99 on 03/11/26 | 150.27 on 03/04/26 | 47.86 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | +4.37% since 12/26/25 | -18.10% since 12/26/25 | +18.46% since 12/26/25 | ||
| Low | 160.36 on 01/20/26 | 135.73 on 03/20/26 | 38.29 on 01/02/26 | ||
| High | 202.41 on 02/06/26 | 186.19 on 01/09/26 | 47.86 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +34.54% since 09/26/25 | +6.31% since 09/26/25 | +32.59% since 09/26/25 | ||
| Low | 135.39 on 09/29/25 | 135.73 on 03/20/26 | 34.79 on 09/29/25 | ||
| High | 202.41 on 02/06/26 | 212.75 on 12/02/25 | 47.86 on 03/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,039,776 | 31,815,478 | 27,077,668 | ||
| Shares Outstanding, K | 146,759 | 215,552 | 576,857 | ||
| Annual Sales | 9,890,600,000 | 606,420,000 | 2,378,190,000 | ||
| Annual Net Income | 1,292,900,000 | -1,276,780,000 | 770,950,000 | ||
| Last Quarter Sales | 2,279,400,000 | 263,840,000 | 621,990,000 | ||
| Last Quarter Net Income | -48,900,000 | -328,490,000 | 214,210,000 | ||
| 60-Month Beta | 0.15 | 1.13 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 02/06/26 | -1.54 on 02/19/26 | 1.46 on 02/11/26 | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | 0.235 on 02/20/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 12.37 | 0.00 | 9.74 | ||